Anbio Biotechnology Class A Ordinary Shares (NNNN) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Anbio Biotechnology Class A Ordinary Shares (NNNN) operates in the Healthcare sector, specifically the Medical - Instruments & Supplies industry, with a market capitalization near $1.44B, listed on NASDAQ, employing roughly 27 people, carrying a beta of 4.66 to the broader market. Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. Led by Michael Lau, public since 2025-02-19.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for NNNN as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →